The discussion centers on the challenges enterprises face in AI adoption, particularly why many AI pilots fail to scale. Nishtha Jain, AI innovation and strategy leader at Takeda Pharmaceuticals, suggests unrealistic expectations, misaligned use cases, and overlooking the human element contribute to this skepticism. Jain argues that enterprises often prioritize technology over understanding real business problems, leading to expensive science experiments rather than valuable solutions. She proposes shifting the focus of ROI from mere cost reduction to include employee experience and long-term compatibility, advocating for faster experimentation, customer-driven use case prioritization, and flexible operating models.
Sign in to continue reading, translating and more.
Continue